プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Annisa Salsabilla D.に依頼

Indonesia

Academic Researcher and Medical Doctor | R, SPSS, STATA, Tableau | 45+ awards, 5+ first author on Q1 publications

プロフィール概要

Annisa Salsabilla Dwi Nugrahani is a medical researcher and future Master’s student at Harvard Medical School (2025-2027), specializing in biomarkers, endocrinology, and clinical investigation. With a strong background in meta-analyses, systematic reviews, and translational research, she has contributed to over 10 publications and presented at international medical conferences. She has won 30+ research competitions, including the Outstanding Abstract Award (JSMO 2024), and secured full funding from the Indonesian Government (LPDP) for her graduate studies. Passionate about bridging research and clinical practice, Annisa aims to advance precision medicine and metabolic disease research, while actively seeking global collaborations in medical science.

専門分野

• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ SPSS
• ☆ STATA
• ☆ R
• ☆ Tableau
• ☆ Primary Care/Family Medicine
• ☆ Preventive Medicine
• ☆ Precision Medicine
• ☆ Internal Medicine

サービス

• Writing

Writing Medical Writing, General Proofreading & Editing

職務経験

Researcher

Advanced Research Center

7月 2023 - 現在

Graduate Research Assistant / Research Assistant

The University of Western Australia

7月 2022 - 1月 2025

Research Assistant - Research Associate

Mahidol University

7月 2022 - 8月 2022

学歴

Doctor of Medicine

Airlangga University

8月 2019 - 1月 2025

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Annisa Salsabilla Dwi Nugrahani, Farizal Rizky Muharram, Hermina Novida, Julian Benedict Swannjo, Sony Wibisono, Citrawati Dyah Kencono Wungu (2025). Trends and disability-attributable risk factors of type 2 diabetes mellitus in Southeast Asia (1990–2019): An in-depth 30-year analysis from the Global Burden of Disease study . Nutrition, Metabolism and Cardiovascular Diseases.

Annisa Salsabilla Dwi Nugrahani, Herni Basir, Andi Makbul Aman, Syakib Bakri, Haerani Rasyid, Husaini Umar, Faridin H. P., Andi Muhammad Ichsan, Andi Alfian Zainuddin (2024). The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression . PeerJ.

M.R. Putra, A.D. Nugrahani (2024). MO61-1 Efficacy of DA-EPOCH-R as first-line therapy for diffuse large B-cell lymphoma: a comprehensive review and meta-analysis . Annals of Oncology.

Annisa Salsabilla Dwi Nugrahani, Gwenny Ichsan Prabowo, Agung Pranoto, Citrawati Dyah Kencono Wungu, Bayu Satria Wiratama (2024). Association of manganese superoxide dismutase Ala16Val gene polymorphism with diabetic retinopathy risk in type 2 diabetes: A systematic review and meta-analysis . Electronic Journal of General Medicine.

Nugrahani, A.S.D., Prabowo, G.I., Pranoto, A., Wungu, C.D.K., Wiratama, B.S.(2024). Association of manganese superoxide dismutase Ala16Val gene polymorphism with diabetic retinopathy risk in type 2 diabetes: A systematic review and meta-analysis . Electronic Journal of General Medicine. 21. (3).

Annisa Salsabilla Dwi Nugrahani, Lintang Cahyaning Ratri, Gwenny Ichsan Prabowo, Jongky Hendro Prajitno(2022). Methylene Blue: a Potential Novel Treatment in Diabetic Foot Ulcer . Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan. 16. (2). Fakultas Kedokteran {UPN} Veteran Jakarta

Annisa Salsabilla Dwi Nugrahani, Yuri Widia(2022). The Utilization of Nanoemulsified Aminolevulinic Acid in Photodynamic Therapy for Actinic Keratosis . International Journal of Research Publications. 114. (1). International Journal of Research Publications